Document is current
Any future updates will be listed below
-
Authors
Harris, Evelyn D.
McGovern, Morgan https://orcid.org/0000-0003-3967-0098
Pernikoff, Sara https://orcid.org/0000-0002-3795-2932
Ikeda, Ren https://orcid.org/0009-0003-4012-7532
Kipnis, Lea
Hannon, William
Sobolik, Elizabeth B.
Gray, Matthew https://orcid.org/0000-0002-4260-9784
Greninger, Alexander L. https://orcid.org/0000-0002-7443-0527
He, Sijia
Chin, Chen-Ni https://orcid.org/0009-0002-1304-8161
Fu, Tong-Ming https://orcid.org/0000-0003-1420-2271
Pancera, Marie https://orcid.org/0000-0001-9217-6270
Boonyaratanakornkit, Jim https://orcid.org/0000-0001-5858-2662
-
Funding
Funding for this research was provided by:
Fred Hutchinson Cancer Research Center (Vaccine and Infectious Disease Division Faculty Initiative)
Fred Hutchinson Cancer Research Center (Evergreen Beyond Pilot Award)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01-AI171186)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA015704)
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 29 January 2026
First Online: 12 February 2026
Competing interests
: J.B. is an inventor of patent applications filed by Fred Hutchinson Cancer Center directed to the 4F11 and MxR antibodies. S.H., C.-N.C., and T.-M.F. were employees of IgM Biosciences. The remaining authors declare no competing interests.
